Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

NCT00722553

Conditions
Bladder Cancer, Bladder Neoplasm, Carcinoma, +20 more
Locations
  • The University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Peachtree Hematology/Oncology Consultants Atlanta, Georgia, United States
  • University of Rochester Cancer Center Rochester, New York, United States
  • University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States
View all 19 locations
View Trial Details
Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

NCT01478685

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 13 locations
View Trial Details
Completed

Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer

NCT02351739

Conditions
Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Durham, North Carolina, United States
  • James Cancer Hospital Columbus, Ohio, United States
View Trial Details
Completed

Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer

NCT01529411

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasm Metastasis, +6 more
Locations
  • Hospital General de Elda Virgen de la Salud Elda, Alicante, Spain
  • ICO-Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
  • ICO-Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Fundació Althaia Manresa, Barcelona, Spain
View all 20 locations
View Trial Details

Related conditions